Rain Therapeutics logo

Rain Therapeutics

Rain Therapeutics is a small Molecules founded in 2017 by Avanish Vellanki.

3

Funding Rounds

$154.0m

Money raised

Overview

Rain Therapeutics is a small Molecules founded in 2017 by Avanish Vellanki.

Funding series

Funding Series Analysis

The company Rain Therapeutics has raised a total of $18.4m in funding over 3 rounds.

Key Insights:

  • Rain Therapeutics Series A round Funding Round 2018: $18.4m
  • Rain Therapeutics Inc. funding round, September 2020: $72.6m
  • Rain Therapeutics Series B round September 2020: $63m
Rain Therapeutics logo
Rain Therapeutics Series A round Funding Round 2018 $18.4m
Rain Therapeutics logo
Rain Therapeutics Inc. funding round, September 2020 $72.6m
Rain Therapeutics logo
Rain Therapeutics Series B round September 2020 $63m

Industries

Rain Therapeutics is active in the following industries:
  • Technology
  • Biomedical engineering
  • Biopharmaceutical
  • Cancer
  • Diagnosis
  • Healthcare
  • Oncology
  • Biology
  • Biotechnology
  • Internal medicine
  • Medicine
  • Engineering
  • Precision Oncology